Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases

被引：6
|
作者：
Sengler, C. [1 ]
Niewerth, M. [1 ]
Kallinich, T. [2 ]
Nimtz-Talaska, A.
Haller, M.
Huppertz, H. -I. [3 ]
Minden, K. [1 ]
机构：
[1] German Rheumatism Res Ctr Berlin, Leibniz Inst, Epidemiol Unit, D-10117 Berlin, Germany
[2] Charite, Childrens Univ Hosp, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany
[3] Klinikum Bremen Mitte, Bremen, Germany
来源：
CLINICAL RHEUMATOLOGY | 2014年 / 33卷 / 01期
关键词：
Children; Disease activity; Flare; H1N1 influenza vaccination; Rheumatic disease; JUVENILE IDIOPATHIC ARTHRITIS; SAFETY; IMMUNOGENICITY;
D O I：
10.1007/s10067-013-2435-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The objective of this study is to evaluate complications and changes in health status (disease activity and flare) in response to the AS03-adjuvanted H1N1 vaccine in children with rheumatic diseases. We conducted a nationwide survey addressing paediatric rheumatology sites who participated in the national paediatric rheumatology database. Ninety patients were documented-38 % under treatment with biologicals-of whom 18 % suffered from complications (10 % local and 8 % systemic) with no relevant changes in median disease activity or flare rate during 4 weeks following the vaccination. The adjuvanted H1N1 influenza vaccine seems to be adequately tolerated in children with rheumatic diseases.
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [21] Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: A prospective cohort study
    Tavares, Fernanda
    Nazareth, Irwin
    Monegal, Javier Sawchik
    Kolte, Ida
    Verstraeten, Thomas
    Bauchau, Vincent
    VACCINE, 2011, 29 (37) : 6358 - 6365
  • [22] Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age
    Langley, Joanne M.
    Reich, Dennis
    Aggarwal, Naresh
    Connor, David
    Lebel, Marc H.
    Gupta, Anil
    Garfield, Hartley
    Li, Ping
    Madan, Anu
    Vaughn, David W.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (08) : 848 - 858
  • [23] Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children
    Ortqvist, Ake
    Bennet, Rutger
    Hamrin, Johan
    Rinder, Malin Ryd
    Lindblad, Hans
    Ohd, Joanna Nederby
    Eriksson, Margareta
    VACCINE, 2015, 33 (22) : 2558 - 2561
  • [24] Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
    Garcia-Sicilia, Jose
    Aristegui, Javier
    Omenaca, Felix
    Carmona, Alfonso
    Tejedor, Juan C.
    Merino, Jose M.
    Garcia-Corbeira, Pilar
    Walravens, Karl
    Bambure, Vinod
    Moris, Philippe
    Caplanusi, Adrian
    Gillard, Paul
    Dieussaert, Ilse
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (10) : 2359 - 2369
  • [25] Immunogenicity and safety of a novel AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan
    Ikematsu, Hideyuki
    Nagai, Hideaki
    Kawashima, Masahiro
    Kawakami, Yasunobu
    Tenjinbaru, Kazuyoshi
    Maeda, Atsushi
    Li, Ping
    Gillard, Paul
    Roman, Francois
    HUMAN VACCINES, 2010, 6 (11): : 888 - 893
  • [26] Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial
    Yang, William H.
    Dionne, Marc
    Kyle, Michael
    Aggarwal, Naresh
    Li, Ping
    Madariaga, Miguel
    Godeaux, Olivier
    Vaughn, David W.
    VACCINE, 2013, 31 (40) : 4389 - 4397
  • [27] AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells
    Howard, Leigh M.
    Goll, Johannes B.
    Jensen, Travis L.
    Hoek, Kristen L.
    Prasad, Nripesh
    Gelber, Casey E.
    Levy, Shawn E.
    Joyce, Sebastian
    Link, Andrew J.
    Creech, C. Buddy
    Edwards, Kathryn M.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (11) : 1786 - 1798
  • [28] Immunogenicity and Efficacy in Hemodialysis Patients of an AS03A-Adjuvanted Vaccine for 2009 Pandemic Influenza A(H1N1): A Nonrandomized Trial
    Dikow, Ralf
    Eckerle, Isabella
    Ksoll-Rudek, Dorothea
    Hampel, Heidrun
    Schwenger, Vedat
    Zeier, Martin
    Schnitzler, Paul
    Sommerer, Claudia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (05) : 716 - 723
  • [29] Safety and immunogenicity of 2010-2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine Results of a randomized trial
    Scheifele, David W.
    Dionne, Marc
    Ward, Brian J.
    Cooper, Curtis
    Vanderkooi, Otto G.
    Li, Yan
    Halperin, Scott A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (01) : 136 - 143
  • [30] Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
    Mohty, Bilal
    Bel, Michael
    Vukicevic, Marija
    Nagy, Monika
    Levrat, Emmanuel
    Meier, Sara
    Grillet, Stephane
    Combescure, Christophe
    Kaiser, Laurent
    Chalandon, Yves
    Passweg, Jakob
    Siegrist, Claire-Anne
    Roosnek, Eddy
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (06): : 896 - 904
12345